Moreover, common signaling pathways also play roles in both diseases, for example, deregulated PIK3/AKT pathway contributed to IPF and lung cancer by activating downstream molecules like Transforming Growth Factor Beta 1 (TGF-β1), which is known as a profibrotic mediator [48, 49]. Here, AKT1 is linked to lung carcinoma.